David Zaccardelli | President and Chief Executive Officer |
Mark Hahn | Chief Financial Officer |
Kathy Rickard | Chief Medical Officer |
Andreas Argyrides | Wedbush Securities |
Boobalan Pachaiyappan | H.C. Wainwright |
Tom Shrader | BTIG |
Welcome to Verona Pharma's Third Quarter 2021 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode. And earlier this morning, Verona Pharma issued a press release announcing its financial results for the three and nine months ended September 30, 2021. A copy can be found in the Investor Relations tab on the corporate website, www.veronapharma.com.
Before we begin, I'd like to remind you that during today's call statements about the company's future expectations, plans and prospects are forward-looking statements.